ArticleThe Journal of infectious diseases2026
Serum IgG1 and IgG3 Antibodies to Chlamydia trachomatis Pgp3 and Hsp60 in Men of Subfertile Couples.
Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOur goal was to investigate immunoglobulin G1 (IgG1) and immunoglobulin G3 (IgG3) antibody responses to Chlamydia trachomatis proteins Pgp3 and Hsp60 in males of subfertile couples and to explore the association of these antibodies with semen parameters and male factor infertility.
methodsSerum samples were collected from 256 male partners of subfertile couples. Serum IgG1 and IgG3 antibodies to C trachomatis Pgp3 and Hsp60 were measured using enzyme immunoassays. Semen samples were analyzed for volume, sperm concentration, and motility according to World Health Organization criteria.
resultsAltogether, 74 (29.8%) men were seropositive to either C trachomatis Pgp3 IgG1 or IgG3, and 67 (27.0%) to either Hsp60 IgG1 or IgG3. Chlamydia trachomatis Pgp3 IgG1 and IgG3 antibodies were associated with impaired sperm motility (asthenozoospermia) (18.6% vs 6.3%, P = .006 for Pgp3 IgG1; and 21.4% vs 8.0%, P = .03 for Pgp3 IgG3). After adjusting for smoking, alcohol risk consumption, and body mass index, the association between serum C trachomatis Pgp3 IgG1 seropositivity and asthenozoospermia remained statistically significant (odds ratio, 3.0 [95% confidence interval, 1.12-8.01]; P = .03). The presence of Hsp60 IgG1 antibody was associated with a higher teratozoospermia index (1.47 ± 0.15 vs 1.39 ± 0.16; P = .001).
conclusionsOur results suggest that prior Chlamydia trachomatis infection, as indicated by Pgp3 seropositivity, may negatively impact male fertility potential by affecting sperm motility and morphology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.